Charles Schwab Investment Management Inc Kronos Bio, Inc. Transaction History

Charles Schwab Investment Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$1.23 - $2.25 $279,475 - $511,236	-227,216 Reduced 93.23%	16,500 $21,000
Q2 2023 Aug 09, 2023	SELL	$1.24 - $1.92 $89,546 - $138,652	-72,215 Reduced 22.86%	243,716 $419,000
Q1 2023 May 11, 2023	BUY	$1.34 - $2.62 $35,397 - $69,209	26,416 Added 9.12%	315,931 $461,000
Q4 2022 Feb 13, 2023	SELL	$1.44 - $3.44 $39,257 - $93,781	-27,262 Reduced 8.61%	289,515 $469,000
Q3 2022 Nov 14, 2022	BUY	$3.35 - $5.55 $113,263 - $187,645	33,810 Added 11.95%	316,777 $1.06 Million
Q2 2022 Aug 15, 2022	BUY	$3.12 - $7.52 $33,421 - $80,554	10,712 Added 3.93%	282,967 $1.03 Million
Q1 2022 May 13, 2022	SELL	$6.26 - $14.42 $87,032 - $200,481	-13,903 Reduced 4.86%	272,255 $1.97 Million
Q4 2021 Feb 11, 2022	BUY	$11.35 - $21.18 $63,253 - $118,036	5,573 Added 1.99%	286,158 $3.89 Million
Q3 2021 Nov 16, 2021	BUY	$18.17 - $24.7 $2.44 Million - $3.32 Million	134,534 Added 92.11%	280,585 $5.88 Million
Q2 2021 Aug 16, 2021	BUY	$20.08 - $29.02 $1.02 Million - $1.47 Million	50,690 Added 53.16%	146,051 $3.5 Million
Q1 2021 May 17, 2021	BUY	$27.0 - $32.48 $108,540 - $130,569	4,020 Added 4.4%	95,361 $2.79 Million
Q4 2020 Feb 16, 2021	BUY	$26.68 - $38.23 $2.44 Million - $3.49 Million	91,341 New	91,341 $2.73 Million

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $53.9M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.